Skip to content
Home/Companies/Biotech/AntalGenics
AntalGenics

AntalGenics

Biotech·Spain·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns AntalGenics?

AntalGenics is currently owned by Inveready Asset Management through Inveready Biotech II (2015 vintage), since 2017.

Hand-verified · updated 2026-08-10

Inveready Asset Management
Investor
Inveready Asset Management
Inveready Biotech II · 2015 · Life Sciences VC

Key facts

HQSpain
SectorBiotech
StatusActive
Websiteantalgenics.com

More from Inveready Biotech II

Other portfolio companies in the same fund.

Medibiofarma
Medibiofarma
Active
BiotechSpain· 2019
Spiral Therapeutics
Spiral Therapeutics
Active
BiotechUnited States· 2019
VIVEbiotech
VIVEbiotech
Active
BiotechSpain· 2019
AptaTargets
Exited 2024
BiotechSpain· 2017
to
BDI Biotech
BDI Biotech
Active
BiotechSpain· 2017
Edesa Biotech
Exited 2019
BiotechCanada· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track AntalGenics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on AntalGenics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue